Overview

Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer

Status:
Not yet recruiting
Trial end date:
2027-09-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of a regimen of selected metabolic treatments for patients with cancer in a real world setting and to conduct exploratory analysis on the relationship between the degree of response and changes in biochemical markers (such as glucose and lipid levels).
Phase:
Phase 3
Details
Lead Sponsor:
Health Clinics Limited
Treatments:
Atorvastatin
Doxycycline
Mebendazole
Metformin